Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Autor: Seib C; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.; School of Nursing and Midwifery, Griffith University, Gold Coast, Queensland, Australia., Harbeck E; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia., Anderson D; University of Technology Sydney, Sydney, New South Wales, Australia., Porter-Steele J; The Wesley Hospital Choices Cancer Support Centre (Choices), Wesley Hospital, Auchenflower, Queensland, Australia.; School of Nursing, Midwifery and Social Work, University of Queensland, St Lucia, Queensland, Australia., Nehill C; Cancer Australia, Strawberry Hills, New South Wales, Australia., Sanmugarajah J; Gold Coast University Hospital, Southport, Queensland, Australia.; School of Medicine, Griffith University, Gold Coast, Queensland, Australia., Perrin L; Mater Hospital and Mater Cancer Care Centre, South Brisbane, Queensland, Australia., Shannon C; Mater Hospital and Mater Cancer Care Centre, South Brisbane, Queensland, Australia., Cabraal N; Mater Hospital and Mater Cancer Care Centre, South Brisbane, Queensland, Australia., Jennings B; Mater Hospital and Mater Cancer Care Centre, South Brisbane, Queensland, Australia., Otton G; Lambton Women's Health, Lambton, New South Wales, Australia., Adams C; Lambton Women's Health, Lambton, New South Wales, Australia., Mellon A; Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, New Lambton Heights, New South Wales, Australia., Chambers S; Faculty of Health Sciences, Australian Catholic University, Banyo, Queensland, Australia.
Jazyk: angličtina
Zdroj: Psycho-oncology [Psychooncology] 2024 Mar; Vol. 33 (3), pp. e6328.
DOI: 10.1002/pon.6328
Abstrakt: Objective: Nuanced distress screening tools can help cancer care services manage specific cancer groups' concerns more efficiently. This study examines the sensitivity and specificity of a tool specifically for women with gynaecological cancers (called the Gynaecological Cancer Distress Screen or DT-Gyn).
Methods: This paper presents cross-sectional data from individuals recently treated for gynaecological cancer recruited through Australian cancer care services, partner organisations, and support/advocacy services. Receiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT-Gyn against criterion measures for anxiety (GAD-7), depression (patient health questionnaire), and distress (IES-R and K10).
Results: Overall, 373 individuals aged 19-91 provided complete data for the study. Using the recognised distress thermometer (DT) cut-off of 4, 47% of participants were classified as distressed, while a cut-off of 5 suggested that 40% had clinically relevant distress. The DT-Gyn showed good discriminant ability across all measures (IES-R: area under the curve (AUC) = 0.86, 95% CI = 0.82-0.90; GAD-7: AUC = 0.89, 95% CI = 0.85-0.93; K10: AUC = 0.88, 95% CI = 0.85-0.92; PHQ-9: AUC = 0.85, 95% CI = 0.81-0.89) and the Youden Index suggested an optimum DT cut-point of 5.
Conclusions: This study established the psychometric properties of the DT-Gyn, a tool designed to identify and manage the common sources of distress in women with gynaecological cancers. We suggest a DT cut point ≥5 is optimal in detecting 'clinically relevant' distress, anxiety, and depression in this population.
(© 2024 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: